Browse Studies — Arctuva

Risk Stratification of Ischemic and Non-ischemic Cardiomyopathies in Racial and Ethnic Minority Groups in the Bronx - Cardiovascular Multimodality Imaging Study

Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk f…

Non-ischemic CardiomyopathyCardiomyopathiesHypertrophic Cardiomyopathy+7 more

Estimated

~$10 – $750

Montefiore Medical CenterNCT06610019

An Observational Study to Assess Real-world Patient Characteristics, Clinical Course, and Treatment Patterns for Symptomatic Patients With Arrhythmogenic Cardiomyopathy (ACM) Due To a PlaKoPhilin-2 Pathogenic Variant (PKP2)

An observational study to assess real-world patient characteristics and clinical course of disease in participants with PKP2-ACM.

Arrhythmogenic CardiomyopathyPKP2-ACMPKP2-ARVC

Estimated

~$10 – $1,050

Lexeo TherapeuticsNCT06976606

Phase 1

A Phase 1 Dose Escalation Trial Evaluating an Intravenously Administered Recombinant Adeno-Associated Virus Serotype rh.74 (AAVrh.74) Vector Containing the Human Plakophilin-2a (PKP2a) Coding Sequence (RP-A601; AAVrh.74-PKP2a) in Subjects With Arrhythmogenic Cardiomyopathy Arising From Pathogenic PKP2 Variants (PKP2-ACM)

This Phase 1 dose escalation trial will assess the safety and preliminary efficacy of a single dose intravenous infusion of RP-A601 in high-risk adult patients…

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Estimated

~$10 – $8,750

Rocket Pharmaceuticals Inc.NCT05885412